首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Perforated balloon technique: A simple and handy technique to combat no‐reflow phenomenon in coronary system
【24h】

Perforated balloon technique: A simple and handy technique to combat no‐reflow phenomenon in coronary system

机译:穿孔气球技术:一种简单方便的技术,用于打击冠状动脉系统中的无回流现象

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objective Examining the efficacy and outcomes of intracoronary (IC) instillation of adenosine using a novel perforated balloon technique (PBT) to combat no‐reflow phenomenon during percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Background Occurrence of no‐reflow during PCI is a serious adverse prognostic event and inability to re‐establish better flow is associated with poor outcomes. Several pharmacological and non‐pharmacological interventions have been used to treat this situation. This series describes the use of PBT for IC adenosine administration and its effects on outcomes during real world interventional practice. Methods Subjects comprised of 24 patients with ACS (out of a total of 1,634 patients undergoing PCI between January 2016 and June 2017) in whom we used PBT for IC administration of adenosine to treat coronary no‐reflow. Results PBT for IC adenosine instillation was used in 24 (1.5%) of 1,634 patients undergoing PCI. TIMI grade III flow was established in 21 patients (87.5%). In two patients (8.3%) TIMI grade II flow was established and in one patient (4.2%) we were unsuccessful. Conclusion We demonstrate the safety and efficacy of a novel strategy for adenosine instillation in the distal coronary bed, the PBT. This technique enables rapid and cost‐effective treatment of no‐reflow phenomenon during PCI for ACS.
机译:摘要目的研究在急性冠状动脉综合征(ACS)经皮冠状动脉介入治疗(PCI)期间,使用新型穿孔球囊技术(PBT)在冠状动脉内灌注腺苷以对抗无再流现象的疗效和结果。背景PCI期间无再流的发生是一个严重的不良预后事件,无法重建更好的血流与不良预后相关。几种药理和非药理干预措施已被用于治疗这种情况。本系列文章介绍了PBT在IC腺苷管理中的应用及其对现实世界中介入实践结果的影响。方法受试者包括24名ACS患者(2016年1月至2017年6月期间共1634名接受PCI的患者),我们使用PBT进行腺苷IC给药治疗冠状动脉无再流。结果1634例PCI患者中24例(1.5%)使用PBT滴注IC腺苷。21名患者(87.5%)建立了TIMI III级血流。两名患者(8.3%)建立了TIMI II级血流,一名患者(4.2%)未成功。结论我们证明了在远端冠状动脉床上滴注腺苷的新策略PBT的安全性和有效性。该技术能够快速且经济有效地治疗ACS患者PCI期间的无再流现象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号